• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FASB Rule Change, Spot Bitcoin ETFs, and the MicroStrategy Playbook Fuel Corporate Bitcoin Adoption

    6/4/24 11:28:48 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SMLR alert in real time by email

    Corporations are turning to Bitcoin to protect themselves from traditional financial risks and benefit from increases in Bitcoin's value. As a liquid asset outside the traditional financial system, Bitcoin allows companies to continue operations and meet short-term obligations, such as paying employees, in case of banking system disruptions.

    A Bitcoin allocation enables companies to benefit from its potential increase in value, as it has been the best-performing asset of the last decade, and global adoption continues to increase. Bitcoin's scarcity and secure, decentralized network make it an attractive store of value compared to less scarce assets traded on centralized networks.

    Impact of FASB Rule Change

    Until recently, public companies rarely held Bitcoin on their balance sheets due to unfavorable accounting rules. However, in September 2023, the Financial Accounting Standards Board (FASB) proposed a rule change that made it more practical for public companies to own Bitcoin.

    Under previous accounting standards, companies had to treat Bitcoin as an indefinite-lived intangible asset, similar to intellectual property. They were required to write down the value of their holdings if they fell below the purchase price, while gains could only be recorded if the Bitcoin was sold. Because of its short-term price volatility, this made it challenging for public companies to maintain an allocation.

    FASB's adoption of fair value accounting for Bitcoin allows companies to report their holdings’ market value accurately. They must regularly assess and disclose the fair market value of their Bitcoin position, capturing unrealized gains and losses quarterly. Full implementation is scheduled for 2025, but firms can adopt standards before then.

    ETF Approvals and the MicroStrategy Playbook

    Since the FASB rule change, two events inspired confidence in corporate leaders regarding Bitcoin. First, the SEC approved spot Bitcoin ETF products, which attracted tens of billions of inflows, exceeding expectations. Various institutional investors, from state pension funds to hedge funds, have gained exposure to Bitcoin's price through these vehicles. Second, Michael Saylor's MicroStrategy successfully executed what is now called the “MicroStrategy playbook,” where a corporation acquires massive amounts of Bitcoin as the firms’ primary reserve asset. As a result, the company's stock price has increased tremendously. MicroStrategy has acquired over 200,000 BTC and even held an annual conference titled “Bitcoin for Corporations.”

    Now, other corporations are implementing the MicroStrategy playbook, likely with more to follow. Semler Scientific, Inc. (NASDAQ:SMLR) announced they are adopting bitcoin as their primary treasury reserve asset, following a similar move by Metaplanet, a Japanese firm. Both companies have seen dramatic increases in their stock price after announcing their Bitcoin strategy.

    Corporate adoption of Bitcoin will increase as institutions seek an alternative to traditional finance’s counterparty risk and recognize Bitcoin's potential as a store of value. This trend may lead to higher Bitcoin allocations among retail consumers. The impact on corporate balance sheets is just beginning, and we can expect more companies to follow MicroStrategy’s lead in the coming months.

    This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

    Get the next $SMLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SMLR

    DatePrice TargetRatingAnalyst
    7/28/2025Overweight
    Cantor Fitzgerald
    7/8/2025$101.00Buy
    The Benchmark Company
    11/2/2022$60.00 → $45.00Buy → Neutral
    B. Riley Securities
    3/7/2022$145.00 → $70.00Buy
    B. Riley Securities
    11/2/2021$175.00 → $145.00Buy
    B. Riley Securities
    10/26/2021$151.00 → $175.00Buy
    B. Riley Securities
    More analyst ratings

    $SMLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Semler Eric returned 714,117 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    1/16/26 3:22:32 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    CEO, interim CFO and Director Murphy-Chutorian Douglas returned 241,303 shares to the company (SEC Form 4)

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    1/16/26 3:21:35 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Messina Daniel S returned 11,910 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    1/16/26 3:20:36 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Semler Scientific Inc.

    SCHEDULE 13G - Semler Scientific, Inc. (0001554859) (Subject)

    2/11/26 3:21:50 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 15-12G filed by Semler Scientific Inc.

    15-12G - Semler Scientific, Inc. (0001554859) (Filer)

    1/26/26 4:16:39 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form EFFECT filed by Semler Scientific Inc.

    EFFECT - Semler Scientific, Inc. (0001554859) (Filer)

    1/22/26 12:15:03 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Semler Scientific

    Cantor Fitzgerald initiated coverage of Semler Scientific with a rating of Overweight

    7/28/25 9:00:02 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    The Benchmark Company initiated coverage on Semler Scientific with a new price target

    The Benchmark Company initiated coverage of Semler Scientific with a rating of Buy and set a new price target of $101.00

    7/8/25 8:33:26 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Semler Scientific from Buy to Neutral and set a new price target of $45.00 from $60.00 previously

    11/2/22 6:23:13 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strive Announces the Completion of Semler Scientific Acquisition

    DALLAS, TX, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific. Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally. Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.  Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Ba

    1/16/26 8:40:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Strive, Inc. (Nasdaq: ASST) and Semler Scientific (Nasdaq: SMLR) Announce Shareholder Approval for Acquisition of Semler Scientific

    DALLAS, TX and CAMPBELL, CA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive") announces Semler Scientific, Inc. ("Semler Scientific") stockholders voted to approve being acquired by Strive. As part of the all-stock transaction, Strive will acquire Semler Scientific's 5,048.1 Bitcoin. Strive also announces the purchase of 123 additional Bitcoin for its corporate treasury at an average price of $91,561 per Bitcoin, for a total purchase price of $11,264,000, inclusive of fees and expenses, bringing Strive's total Bitcoin holdings to 7,749.8. Upon completion of the Semler Scientific acquisition, the combined company will hold 12,797.9 Bitcoin, surpassing both Tesla and Trump Media &

    1/13/26 12:02:00 PM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® to Release Third Quarter 2025 Financial Results

    CAMPBELL, Calif., Oct. 28, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, Inc., the company will not be hosting a conference call or providing an accompanying earnings presentation in conjunction with its third quarter 2025 financial results. Semler Scientific intends to file its Quarterly Report on Form 10-Q for the period ended September 30,

    10/28/25 5:05:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Semler Eric was granted 1,318 shares and bought $1,896,500 worth of shares (50,000 units at $37.93), increasing direct ownership by 9% to 621,721 units (SEC Form 4)

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    11/12/24 6:05:40 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Leadership Updates

    Live Leadership Updates

    View All

    Strive Announces the Completion of Semler Scientific Acquisition

    DALLAS, TX, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific. Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally. Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.  Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Ba

    1/16/26 8:40:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction

    DALLAS, TX and CAMPBELL, CA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive") entered into a definitive agreement to acquire Semler Scientific, Inc. ("Semler Scientific") in an all-stock transaction. In addition, Strive announced the purchase of 5,816 Bitcoin to its corporate treasury at an average price of $116,047 per Bitcoin, for a total purchase price of $675,000,000, inclusive of fees and expenses, bringing Strive's total Bitcoin holdings to 5,886. Transaction details: Deal represents an approximately 210% premium, equivalent to approximately $90.52 per share, based on the trading price of Semler Scientific common stock and Strive Class A common stock as of the market clos

    9/22/25 8:15:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Appoints Joe Burnett as Director of Bitcoin Strategy; Targets Owning at Least 10,000 Bitcoins by Year-End 2025 and 105,000 by Year-End 2027

    CAMPBELL, Calif., June 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Joe Burnett as director of Bitcoin strategy. Semler Scientific also announced that it plans to hold 10,000 Bitcoins by year-end 2025, 42,000 by year-end 2026 and 105,000 by year-end 2027, using proceeds from equity and debt financings and cash flows from operations.  "We are excited to have Joe join our Bitcoin strategy

    6/19/25 4:45:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by Semler Scientific Inc.

    SC 13G - Semler Scientific, Inc. (0001554859) (Subject)

    11/26/24 12:09:40 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    11/12/24 4:15:46 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Financials

    Live finance-specific insights

    View All

    Semler Scientific® to Release Third Quarter 2025 Financial Results

    CAMPBELL, Calif., Oct. 28, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, Inc., the company will not be hosting a conference call or providing an accompanying earnings presentation in conjunction with its third quarter 2025 financial results. Semler Scientific intends to file its Quarterly Report on Form 10-Q for the period ended September 30,

    10/28/25 5:05:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025

    CAMPBELL, Calif., Aug. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, today reported financial results for the second quarter ended June 30, 2025 and provided an update on its Bitcoin holdings and other key performance indicators (KPIs). "We have made excellent progress with our Bitcoin treasury strategy," said Eric Semler, executive chairman of Semler Scientific. "We purchased approximately $195.4 million of Bitcoin s

    8/4/25 4:01:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC

    CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we a

    5/13/25 4:01:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care